Literature DB >> 20188546

Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structure-activity relationship of the quinazoline ring.

Nilantha Sirisoma1, Azra Pervin, Hong Zhang, Songchun Jiang, J Adam Willardsen, Mark B Anderson, Gary Mather, Christopher M Pleiman, Shailaja Kasibhatla, Ben Tseng, John Drewe, Sui Xiong Cai.   

Abstract

As a continuation of our efforts to discover and develop apoptosis inducing N-methyl-4-(4-methoxyanilino)quinazolines as novel anticancer agents, we explored substitution at the 5-, 6-, 7-positions of the quinazoline and replacement of the quinazoline by other nitrogen-containing heterocycles. A small group at the 5-position was found to be well tolerated. At the 6-position a small group like an amino was preferred. Substitution at the 7-position was tolerated much less than at the 6-position. Replacing the carbon at the 8-position or both the 5- and 8-positions with nitrogen led to about 10-fold reductions in potency. Replacement of the quinazoline ring with a quinoline, a benzo[d][1,2,3]triazine, or an isoquinoline ring showed that the nitrogen at the 1-position is important for activity, while the carbon at the 2-position can be replaced by a nitrogen and the nitrogen at the 3-position can be replaced by a carbon. Through the SAR study, several 5- or 6-substituted analogs, such as 2a and 2c, were found to have potencies approaching that of lead compound N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine (1g, EP128495, MPC-6827, Azixa). 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188546     DOI: 10.1016/j.bmcl.2010.01.155

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Synthesis and discovery of water-soluble microtubule targeting agents that bind to the colchicine site on tubulin and circumvent Pgp mediated resistance.

Authors:  Aleem Gangjee; Ying Zhao; Lu Lin; Sudhir Raghavan; Elizabeth G Roberts; April L Risinger; Ernest Hamel; Susan L Mooberry
Journal:  J Med Chem       Date:  2010-10-25       Impact factor: 7.446

2.  Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy.

Authors:  Souvik Banerjee; Kinsie E Arnst; Yuxi Wang; Gyanendra Kumar; Shanshan Deng; Lei Yang; Guo-Bo Li; Jinliang Yang; Stephen W White; Wei Li; Duane D Miller
Journal:  J Med Chem       Date:  2018-02-12       Impact factor: 7.446

3.  Discovery of biarylaminoquinazolines as novel tubulin polymerization inhibitors.

Authors:  Giovanni Marzaro; Antonio Coluccia; Alessandro Ferrarese; Paola Brun; Ignazio Castagliuolo; Maria Teresa Conconi; Giuseppe La Regina; Ruoli Bai; Romano Silvestri; Ernest Hamel; Adriana Chilin
Journal:  J Med Chem       Date:  2014-05-14       Impact factor: 7.446

4.  A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).

Authors:  Marc C Chamberlain; Sean Grimm; Surasak Phuphanich; Larry Recht; Jay Z Zhu; Lyndon Kim; Steve Rosenfeld; Camilo E Fadul
Journal:  J Neurooncol       Date:  2014-04-17       Impact factor: 4.130

5.  A novel quinoline derivative that inhibits mycobacterial FtsZ.

Authors:  Bini Mathew; Larry Ross; Robert C Reynolds
Journal:  Tuberculosis (Edinb)       Date:  2013-05-04       Impact factor: 3.131

Review 6.  An insight into the therapeutic potential of quinazoline derivatives as anticancer agents.

Authors:  Irshad Ahmad
Journal:  Medchemcomm       Date:  2017-04-07       Impact factor: 3.597

Review 7.  MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents-A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives.

Authors:  Monika Szewc; Elżbieta Radzikowska-Bűchner; Paulina Wdowiak; Joanna Kozak; Piotr Kuszta; Ewa Niezabitowska; Joanna Matysiak; Konrad Kubiński; Maciej Masłyk
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

Review 8.  Microtubule Depolymerization by Kinase Inhibitors: Unexpected Findings of Dual Inhibitors.

Authors:  Kenji Tanabe
Journal:  Int J Mol Sci       Date:  2017-11-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.